2022 annual financial data
Nektar Therapeutics 2022 Operating margin
Nektar Therapeutics 2022 operating margin with verified reported values.
Direct answer
Operating margin was -260.97%.
Operating income was -240,236,000 USD and net income was -368,198,000 USD.
Operating cash flow was -304,007,000 USD.
Get free Nektar Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 92,055,000 USD
- Operating income
- -240,236,000 USD
- Net income
- -368,198,000 USD
- Operating cash flow
- -304,007,000 USD